Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$344.87NASDAQ Previous Close - Last Trade as of 3:59PM ET 11/15/19

Today's Change0(0.00%)
Bid (Size)$330.12 (4)
Ask (Size)$344.87 (1)
Day Low / HighN/A - N/A
Volume912.2 K

View Biotechnology IndustryPeer Comparison as of 11/15/2019


Regeneron Pharmaceuticals Inc ( NASDAQ )

Price: $344.87
Change: +6.48 (1.91%)
Volume: 912.2 K
3:59PM ET 11/15/2019

Illumina Inc ( NASDAQ )

Price: $305.99
Change: +7.55 (2.53%)
Volume: 750.2 K
4:00PM ET 11/15/2019

Agilent Technologies Inc ( NYSE )

Price: $78.25
Change: -0.01 (0.01%)
Volume: 1.7 M
4:00PM ET 11/15/2019

Alexion Pharmaceuticals Inc ( NASDAQ )

Price: $108.37
Change: +2.48 (2.34%)
Volume: 1.8 M
4:00PM ET 11/15/2019

Biogen Inc ( NASDAQ )

Price: $282.27
Change: +7.12 (2.59%)
Volume: 1.9 M
4:00PM ET 11/15/2019

Read more news Recent News

Analyst Actions: SunTrust Initiates Regeneron Pharmaceuticals at Hold With $360 Price Target
7:54AM ET 11/12/2019 MT Newswires

Regeneron Pharmaceuticals (REGN) has an average rating among analysts of buy, with an average price target of $386. Price: 344.28, Change: +2.49, Percent...

Insider Trends: Insider 90-Day Selling Trend Continued at Regeneron Pharmaceuticals
5:06PM ET 11/08/2019 MT Newswires

Dr Joseph L Goldstein, Director, on Nov 08, 2019, sold 1,000 shares in Regeneron Pharmaceuticals (REGN) for $340,440. Following the Form 4 filing with the...

Stocks Close at Record Highs Despite Conflicting Trump Remarks on Tariff Rollbacks
4:52PM ET 11/08/2019 MT Newswires

Stocks ended at record highs on Friday even as President Donald Trump said he had not agreed to roll back tariffs on Chinese-produced goods, a day after...

Consensus Estimates for Regeneron Pharmaceuticals' Q4, 2019, 2020 Years Scaled Up
9:51PM ET 11/07/2019 MT Newswires

Regeneron Pharmaceuticals Inc's (NASDAQ:REGN, Recent Price: 324.49) consensus forecasts for Q4 ending December 31, 2019, and the full year estimates for...

View all Commentary and Analysis

Retailers, Dubai Airshow And Cybertrucks (Stocks To Watch Podcast)
7:30AM ET 11/17/2019 Seeking Alpha

Stocks To Watch: Retailers, Dubai Airshow And Cybertrucks
7:10AM ET 11/16/2019 Seeking Alpha

Regenxbio: Amid Temporary Difficulty Is A Buying Opportunity
1:16AM ET 11/15/2019 Seeking Alpha

4 RNA Therapy Stocks For A Biotech Portfolio
2:20PM ET 11/07/2019 Seeking Alpha

Company Profile

Business DescriptionRegeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. View company web site for more details
Address777 Old Saw Mill River Road
Tarrytown, New York 10591-6707
Number of Employees7,400
Recent SEC Filing11/13/20194
Co-President, Chief Executive Officer & DirectorLeonard S. Schleifer
Co-President, Director & Chief Scientific OfficerGeorge Damis Yancopoulos
Chief Financial Officer & Executive VP-FinanceRobert E. Landry
Chief Compliance Officer & Senior Vice PresidentBeth F. Levine

Company Highlights

Price Open$340.95
Previous Close$338.39
52 Week Range$271.37 - 442.00
Market Capitalization$37.2 B
Shares Outstanding107.9 M
SectorHealth Technology
Next Earnings Announcement02/05/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings18.46
Earnings per Share$19.43
Beta vs. S&P 500N/A
Revenue$6.7 B
Net Profit Margin28.13%
Return on Equity22.30%

Analyst Ratings as of 11/15/2019

Consensus RecommendationConsensus Icon
Powered by Factset